Audited Plant & CRO Case Studies
Supporting Africa's GMP plants & trial networks.
BioKinetyc operates as the validated autonomous quality and pharmacovigilance backbone for pharmaceutical contract manufacturers, analytical QC laboratories, and clinical research organizations across Nigeria. Review their audited outcomes and official Corporate Affairs Commission (CAC) registrations.
Agbara Industrial Estate, Ogun / Lagos Corridor
1,400+ Annual GMP Batches (Oral Solid Dosage & Pediatric Suspensions)
Africure Bio-Manufacturing & Formulations Plc
CAC Reg: RC 1329481 • Active & Verified (WHO-GMP / PCN)
“Prior to BioKinetyc, our finished Artemether-Lumefantrine and Ciprofloxacin batches sat in quarantine for 14 days awaiting manual HPLC chromatogram integration and wet-chemistry binder signoffs. AssayVision™ integrated directly with our Waters Empower-3 cluster, reducing QC release turnaround to 6 hours and saving over ₦320M in prevented batch write-offs and working-capital delays.”
₦320M+
Saved in Prevented Quarantine Losses
6 Hrs (from 14d)
QC Batch Release Turnaround
< 340ms
HPLC Impurity Triage Speed
BioKinetyc GxP Modules Deployed:
- AssayVision™ (SpectraViT-QC-v4) Waters Empower-3 & Blister Line Optical Sync
- Automated USP/BP Certificate of Analysis (COA) & 21 CFR Part 11 Vault
- TrialEscrow™ Multi-Currency Raw API Letter-of-Credit Settlement
Quality Assurance & Qualified Person (QP) Directorate
Verified 21 CFR Part 11 Institutional Partition
Central Area, Abuja FCT & Ibadan University Teaching Corridor
18 Multi-Center Phase II–IV Clinical Trials (4,800+ Enrolled Patients)
PanAfrica Clinical Research & Pharmacovigilance CRO Ltd
CAC Reg: RC 1584920 • Active & Verified (NHREC / NAFDAC CRO)
“Coordinating 18 multi-center trials across Abuja, Ibadan, and Lagos required parsing thousands of unstructured adverse-event narratives with complex antimalarial polypharmacy. VigilanceSentinel™ delivered 99.8% MedDRA v27.0 coding concordance and automated our ICH-E2B(R3) safety filings to NAFDAC while TrialEscrow™ cut investigator grant disbursements to under 30 minutes.”
99.8%
MedDRA v27.0 Coding Concordance
28 Mins (from 60d)
Investigator Grant Disbursement
2,150 Hours/yr
Clinical CRA Audit Hours Saved
BioKinetyc GxP Modules Deployed:
- VigilanceSentinel™ (MedDRA-NLP-v3) Adverse Event & CYP450 Risk Engine
- TrialEscrow™ Multi-Site Investigator Milestone & eCRF Lock Payouts
- Azure Confidential Computing Patient Biomarker Privacy Enclaves
Clinical Safety & DSMB Pharmacovigilance Board
Verified 21 CFR Part 11 Institutional Partition
Emene Industrial Layout, Enugu & Sharada Phase II, Kano
1,100+ Sterile Injectable & Lyophilized Vial Lots Annually
NileValley Active Ingredients & Parenterals Ltd
CAC Reg: RC 1694028 • Active & Verified (Sterile GMP Licensed)
“In sterile parenteral manufacturing, a single sub-visible glass delamination particle or ampoule neck micro-crack can trigger a catastrophic recall. BioKinetyc’s dark-field AssayVision™ array and DossierLex™ Climatic Zone IVb stability compiler gave us zero batch recalls across 1,100 sterile lots and a 99.4% first-cycle NAFDAC CTD approval rate.”
0 Recalls (1,100 Lots)
Post-Market Batch Recalls
99.4%
First-Cycle NAFDAC CTD Approval
99.92% (2°C–8°C)
Cold-Chain Custody Integrity
BioKinetyc GxP Modules Deployed:
- Dark-Field Polarized AssayVision™ for USP <788> Particulate & Ampoule Cracks
- DossierLex™ Automated ICH M4 eCTD & Zone IVb Stability Compiler
- SAP QM Bidirectional Release & Cold-Chain IoT Custody Telemetry
Sterile Parenteral QA & Regulatory Affairs Committee
Verified 21 CFR Part 11 Institutional Partition
Aggregate operational telemetry across verified life-sciences facilities.
3,400+
Active Batch & Trial Protocols
₦1.72M+
Monthly Recurring Revenue (MRR)
21 Orgs
Active Pharma CMOs, Labs & CROs
99.8%
MedDRA & COA Audit Concordance